ALGS - Aligos Therapeutics, Inc.

QQQ $ 441.33 $ 0.96 (0.22 %)

DIA $ 394.43 $ 3.52 (0.9 %)

SPY $ 520.56 $ 2.98 (0.58 %)

TLT $ 90.69 $ 0.44 (0.49 %)

GLD $ 216.93 $ 3.37 (1.58 %)

Previous Close

$ 0.7765

Open

$ 0.78

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.77 - $ 0.79

52 Week Range

$ 0.54 - $ 1.34

Volume

162,965

Average Volume

Market Cap

121.25M

Beta (5Y Monthly)

$ 1.49

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	03-12-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-03-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	03-09-2023	12-31-2022	10-K
7	11-02-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	03-10-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-10-2021	03-31-2021	10-Q
14	03-23-2021	12-31-2020	10-K
15	11-25-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Aligos Therapeutics Q1 2024 GAAP EPS $(0.2...
05/07/2024 21:07:05

Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of...

Aligos Therapeutics Presents Clinical Data...
04/25/2024 20:26:40

Data demonstrates a 7-day treatment regimen with the pan-coronavirus protease inhibitor ALG-097558 was well tolerated and does ...

Aligos Therapeutics Announces First Subjec...
04/03/2024 12:18:26

Earlier Announced, Aligos Therapeutics Has...
04/01/2024 15:31:25

https://www.fpds.gov/common/jsp/LaunchWebPage.jsp?command=execute&requestid=172813877&version=1.5

Aligos Therapeutics Presents Clinical Data...
03/27/2024 12:06:58

Aligos Therapeutics, Inc. (NASDAQ:ALGS, ", Aligos", )))), a clinical stage biopharmaceutical company focused on develop...

Aligos Therapeutics Announces Initiation O...
03/18/2024 12:01:17

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
03/15/2024 21:33:52

Recap: Aligos Therapeutics Q4 Earnings
03/12/2024 20:30:33

Aligos Therapeutics Q4 2023 GAAP EPS $(0.2...
03/12/2024 20:26:30

Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $...

Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Aligos Therapeutics Earnings Preview
03/11/2024 18:00:49

Aligos Therapeutics To Host KOL Event To D...
02/20/2024 13:30:57

Aligos Therapeutics, Inc. (NASDAQ:ALGS, "Aligos")))), a clinical stage biopharmaceutical company focused on developing ...

why-hello-group-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket

Why Hello Group Shares Are Trading Higher ...
12/08/2023 13:05:42

Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter.

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
12/07/2023 21:31:07

Aligos Therapeutics Presents Clinical Data...
12/07/2023 21:18:11

Aligos Therapeutics, Inc. (NASDAQ:ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to...

why-applied-uv-shares-are-trading-higher-by-around-96-here-are-20-stocks-moving-premarket

Why Applied UV Shares Are Trading Higher B...
11/20/2023 13:19:26

Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results.

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
11/20/2023 13:06:36

Aligos Therapeutics Inc Files Prospectus R...
11/17/2023 21:42:25

- SEC Filing

Aligos Therapeutics Presents Clinical And ...
11/13/2023 13:05:09

Aligos Therapeutics Presents Data At The A...
11/10/2023 13:10:33

Hepatitis B virus e antigen positive (HBeAg+) subjects dosed with once-daily 300mg ALG-000184 + entecavir for up to 48 weeks de...